The reduction by Ed Yardeni, president and chief investment strategist of Yardeni Research, is notable for a few reasons, one being that he was one of the top bulls on Wall Street. (Oppenheimer as of ...

What next for the SCHD ETF now that analysts at Citigroup, Goldman Sachs, and HSBC have slashed their S&P 500 forecast?

Get Free Report) had its price target cut by stock analysts at UBS Group from $1,250.00 to $1,000.00 in a report released on ...

Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the pricing of an upsized ...

Tarsus Pharmaceuticals (TARS) announced the commencement of an underwritten public offering of $100M of shares of its common stock. All shares ...

Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (the “Company” or “Tarsus”) today announced the commencement of an underwritten ...

Representative Marjorie Taylor Greene (R-Georgia) recently bought shares of The Goldman Sachs Group, Inc. (NYSE:GS). In a ...

U.S. President Donald Trump has nominated John Squires, the former chief intellectual property attorney at banking giant ...

In a report released today, Kash Rangan from Goldman Sachs maintained a Hold rating on Oracle (ORCL – Research Report), with a price target of ...

Stocks dropped as the selling pressures that dragged Wall Street last week persisted, while investors braced for a slew of ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options ...

This Wall Street expert believes that the benchmark S&P 500 stock index might fall more than 20% in 2025 as the US might be ...